Metastatic oncocytic adrenocortical carcinoma of mandible: an extraordinarily rare occurrence

Published:February 03, 2022DOI:
      Adrenocortical carcinoma (ACC) is an uncommon primary cancer in the adrenal gland. Its incidence of showing metastasis in the head and neck region is very rare. Herein, we present a case of a 46-year-old man who presented with complaints of pain and numbness on the left side of the lower face for 4 months. Radiographic examination revealed an osteolytic lesion with an ill-defined border in the left body region of the mandible. Histopathologic examination revealed a tumor composed of sheets of oval to polygon-shaped tumor cells predominantly displaying abundant eosinophilic granular cytoplasm. These tumor cells showed features of a high degree of anaplasia. On immunohistochemical examination, tumor cells were focally positive for synaptophysin, inhibin, vimentin, pancytokeratin (pan-CK), cytokeratin (CK)5/6, CD68, and CK8/18 and immunonegative for CK7, chromogranin, melan-A, S100, SMA, and SATB2. The Ki-67 proliferation index was approximately 20%. To the best of our knowledge, this is the first case of metastatic oncocytic ACC to the oral cavity region.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Hirshberg A
        • Shnaiderman-Shapiro A
        • Kaplan I
        • Berger R.
        Metastatic tumours to the oral cavity – pathogenesis and analysis of 673 cases.
        Oral Oncol. 2008; 44: 743-752
        • Akinbami BO.
        Metastatic carcinoma of the jaws: a review of literature.
        Niger J Med. 2009; 18: 139-142
        • Dominici A
        • Rizzo M
        • Travaglini F
        • Nesi G
        • Franchi A.
        Non-functioning adrenal cortical carcinoma presenting with metastasis to the tongue.
        J Oral Pathol Med. 2003; 32: 185-187
        • Nakata M
        • Yamashita T
        • Watanabe Y
        • Ono H
        • Kirimoto K.
        Nonfunctioning adrenocortical carcinoma revealed by metastasis to the base of the tongue.
        Gan No Rinsho. 1986; 32 ([in Japanese]): 1855-1859
        • Rachapalli V
        • Blanco-Guzman M
        • Jones GM
        • Oriolowo A.
        Interesting case: metastatic adrenal adenocarcinoma of the mandible.
        Br J Oral Maxillofac Surg. 2006; 44: 239
        • Nakamura Y
        • Yamazaki Y
        • Felizola SJ
        • et al.
        Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
        Endocrinol Metab Clin North Am. 2015; 44: 399-410
        • Lam AK.
        Adrenocortical carcinoma: updates of clinical and pathological features after renewed World Health Organisation classification and pathology staging.
        Biomedicines. 2021; 9: 175
        • Renaudin K
        • Smati S
        • Wargny M
        • et al.
        Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.
        Mod Pathol. 2018; 31: 1708-1716
        • Kanitra JJ
        • Hardaway JC
        • Soleimani T
        • Koehler TJ
        • McLeod MK
        • Kavuturu S.
        Adrenocortical oncocytic neoplasm: a systematic review.
        Surgery. 2018; 164: 1351-1359
        • Wick MR
        • Cherwitz DL
        • McGlennen RC
        • Dehner LP.
        Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.
        Am J Pathol. 1986; 122: 343-352
        • Cote RJ
        • Cordon-Cardo C
        • Reuter VE
        • Rosen PP.
        Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex.
        Am J Pathol. 1990; 136: 1077-1084
        • Fassnacht M
        • Dekkers OM
        • Else T
        • et al.
        European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
        Eur J Endocrinol. 2018; 179: G1-G46
        • Morimoto R
        • Satoh F
        • Murakami O
        • et al.
        Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.
        Endocr J. 2008; 55: 49-55
        • Vargas MP
        • Vargas HI
        • Kleiner DE
        • Merino MJ.
        Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.
        Am J Surg Pathol. 1997; 21: 556-562